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Edited by Angel NebradaAbstract The c-MYC proto-oncogene encodes a ubiquitous
transcription factor involved in cell proliferation and tumorigen-
esis. Heat shock protein 60 (HSP60) plays an essential role in
assisting many newly synthesized proteins to reach their native
forms. Increased HSP60 expression is observed in diﬀerent types
of human cancer. Here we show that c-MYC directly activates
HSP60 transcription through an E-box (CACGTG) site located
in the proximal promoter of the HSP60 gene. Overexpression
of HSP60 induces transformation. Short-interference RNA
(siRNA) mediated repression of HSP60 reduces transformation
caused by c-MYC overexpression. These results indicate that c-
MYC may promote transformation through the induction of
HSP60 expression.
 2008 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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c-MYC proto-oncogene is involved in the control of cell cycle
progression, proliferation, metabolism, and apoptosis [1,2]. The
expression of c-MYC protein is tightly controlled during cell
proliferation and diﬀerentiation [1,2]. c-MYC is one of the most
frequently altered genes in human cancer and deregulation of
c-MYC is constantly implicated in tumorigenesis [1,3,4]. Many
c-MYC target genes were identiﬁed which are linked to prolifer-
ation, transformation, and metabolism [2]. Although many
c-MYC target genes were identiﬁed, genes responsible for
inducing transformation still remain to be explored.
Heat shock protein 60 (HSP60) is the major component of
the chaperonins complex which weighs nearly a million
Daltons and is composed of back-to-back rings of identical
or closely related rotationally symmetric subunits [5,6].
HSP60 plays an essential role in assisting a large variety of
newly synthesized proteins to reach their native forms by bind-
ing and facilitating their folding into native status inside a
large central channel within each ring, as demonstrated in
the bacterial GroEL–GroES–ATP complex [5–7]. However,
folding of native proteins by a single domain was demon-
strated in the mammalian HSP60 protein [8], which is diﬀerentAbbreviations: HSP60, heat shock protein 60; ChIP, chromatin
immunoprecipitation
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doi:10.1016/j.febslet.2008.11.004from the bacterial model [5–7]. HSP60 was mostly shown to be
involved in innate immunity and cardiac diseases [9,10]. In-
creased HSP60 expression is observed in diﬀerent types of hu-
man cancers (ovarian cancer, pancreatic cancer, large bowel
carcinoma, etc.) [11–13]. However, the role of HSP60 in
tumorigenesis remains relatively unknown.
In this report, we demonstrated the tight correlation between
c-MYC and HSP60 expression and direct regulation of HSP60
expression by c-MYC through an E-box site located in the
proximal promoter of the HSP60 gene. Overexpression of
HSP60 induces transformation in a Rat1a cell line. Short-inter-
ference RNA (siRNA) mediated repression of endogenous
HSP60 expression in RatMyc cells causes a signiﬁcant decrease
in transformation. These results indicate that activation of
HSP60 expression by c-MYC is critical for c-MYC mediated
transformation.2. Materials and methods
2.1. Cell lines, plasmids, and reagents
The lymphoblastoid cell lines (CB33 control, CBMyc.Max, and
CBMax), U937, EREB.TCMyc, Rat.MycER, RatMyc, 293TMyc-
si, and HeLaMyc-si cell lines were previously described [14,15]. The
construction of diﬀerent plasmids including the vector backbones,
restriction sites, inserted fragments, and the oligonucleotides used in
the construction of plasmids were described (Supplementary Tables 1
and 2). The generation of stable clones by calcium phosphate transfec-
tion was described [14]. All the stable clones were established by trans-
fection of plasmids as designated by the name of the clones. The
construction of pSUPER-siRNA plasmids were performed using the
oligonucleotides as described (Supplementary Table 3). All the siRNA
stables clones were designated by the suﬃx ‘‘-si’’. 4-Hydroxytamoxifen
and cycloheximide were previously described [14].
2.2. RNA puriﬁcation, Northern blot analysis, protein extraction, and
Western blot analysis
RNA puriﬁcation and Northern blot analysis were previously de-
scribed [14–16]. The HSP60 probe was generated from the full length
cDNA of HSP60 (Supplementary Table 1). The b-actin, GAPDH,
vimentin, c-MYC exon 1 and 3 probes were described [14–16]. The
extraction of proteins from cells and Western blot analysis were per-
formed as described [14,15]. The characteristics of the antibodies used
were listed (Supplementary Table 4). Data shown here are representa-
tive of two or more experiments from independent cell cultures.
2.3. Cloning of the human HSP60 promoter region, generation of HSP60
promoter-driven reporter constructs, transient transfection, and
luciferase assays
The HSP60 promoter region (541 to +16 bp surrounding the tran-
scription start site) was cloned by PCR ampliﬁcation of 293T genomic
DNA and it was inserted into the HindIII/BglII sites of the pXP2 vec-
tor to generate the pHSP60PWLuc parental construct (Fig. 2B) [14,16].
The pHSP60PMLuc mutant construct was made by site-directed
mutagenesis of the pHSP60PWLuc vector (Fig. 2B). The reporterblished by Elsevier B.V. All rights reserved.
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pMT2TMyc, or its deletion mutants [14–16]. A pCMV-b-gal plasmid
was used as an internal control. The luciferase activities were assayed
as described [14].
2.4. Chromatin immunoprecipitation (ChIP) assay
ChIP assay was performed as described [15]. Brieﬂy, cells were cross-
linked and harvested. The lysates were incubated with no antibody or
antibodies speciﬁc for c-Rel or c-MYC. The DNA fragments were ex-
tracted and resuspended for PCR analysis. The PCR reaction gener-
ated a 220 bp product from HSP60 proximal promoter (550 to
331 bp) containing E-box (523 to 518 bp), two 220 bp products
from the HSP60 intron 1 region containing E-boxes (+232 to
+237 bp, +460 to +465 bp), or a 265 bp product from the distal pro-
moter region (1844 to 1580 bp) without E-box. The regions in
the HSP90A gene promoter which were used in the control ChIP
experiments were described [17]. The primers and antibodies used in
the ChIP assays were listed (Supplementary Tables 3 and 4).
2.5. Soft agar colony formation assay
The stable clones were plated at three diﬀerent cell density (5 · 103,
104, 2 · 104) using standard assay conditions as mentioned except that
15% fetal calf serum was used [15,17]. Data shown here are represen-
tative of two or more experiments from independent cell cultures.3. Results
3.1. Correlation between c-MYC and HSP60 expression
To identify c-MYC target genes involved in transformation,
we screened a cDNA microarray ﬁlter (Atlas Human array,
Clontech) using cDNA probes generated from a previouslyFig. 1. Activation of HSP60 expression by c-MYC in a variety of cell lines
estrogen (E2) withdrawal (lanes 2–4) and c-MYC activation by tetracycline (T
c-MYC. The same blot was sequentially hybridized with the indicated probes
lymphoblastoid cell lines (CB33 control, CBMyc.Max, and CBMax) showed
blot was sequentially hybridized with the indicated probes. (C) Western blo
CBMax cells using an anti-HSP60 antibody and an anti-b-actin antibody as
expression in U937 cells with or without TPA induction by Northern b
overexpressing c-MYC (RatMyc) vs. the control RatCMV cells by Western b
HSP60 levels in the 293T or HeLa clone expressing siRNA against c-MYCcharacterized B cell line (EREB.TCMyc) [14–17]. Among
numerous genes overexpressed in c-MYC expressing cells, we
focused on the gene HSP60 due to the increased HSP60
expression in diﬀerent tumor types [11–13]. Northern blot
analysis showed that withdrawal of estrogen and tetracycline
(causing induction of exogenous c-MYC) caused a 2-fold in-
crease in the expression of HSP60 (Fig. 1A). HSP60 expres-
sion signiﬁcantly increased (2.5-fold) in CBMyc.Max cells
when compared to the control lymphoblastoid cells (CB33
control) or CBMax cells (Fig. 1B). Western blot analysis
showed that the increase in HSP60 protein expression also
coincided with the increase in its mRNA levels (Fig. 1C). To
conﬁrm this correlation in diﬀerent cell types, mRNA levels
of HSP60 were shown to decrease in U937 cells induced into
diﬀerentiation by TPA, which correlated with the decline in
c-MYC expression (Fig. 1D). Rat HSP60 protein levels also in-
creased (2-fold) in RatMyc cells overexpressing c-MYC com-
pared with the control RatCMV cells (Fig. 1E). To test
whether HSP60 expression is regulated by endogenous c-
MYC, we performed siRNA experiments on 293T and HeLa
cells to knockdown endogenous c-MYC expression [15,17].
The results showed that endogenous c-MYC expression was
repressed in the 293TMyc-si and HeLaMyc-si clones followed
by a corresponding decrease in the HSP60 protein levels
compared to the control 293T and HeLa clones (Fig. 1F and
G), demonstrating the regulation of HSP60 by endogenous
c-MYC. All the results demonstrated the tight correlation be-
tween c-MYC and HSP60 expression.. (A) Northern blot analysis of RNA from EREB.TCMyc cells upon
C) withdrawal (lane 4) showed the activation of HSP60 expression by
(see Section 2). (B) Northern blot analysis of RNA from diﬀerent CB33
the correlation between c-MYC and HSP60 gene expression. The same
t analysis of the cell lysates from the CB33 control, CBMyc.Max, and
a control for protein loading. (D) Correlation of HSP60 vs. c-MYC
lot analysis. (E) Increased rat HSP60 protein levels in Rat1a cells
lot analysis. (F) and (G) Western blot analysis showed the decrease in
(293TMyc-si or HeLaMyc-si) vs. the control 293T or HeLa clone.
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To investigate whether c-MYC-mediated upregulation of
HSP60 expression was direct, we studied HSP60 expression
in a Rat.MycER cell line previously described [14,15,17].
By treating the cells with 4-hydroxytamoxifen (TM), which
speciﬁcally activates MycER, and by simultaneous treatment
with cyclohexamide (CX) to inhibit new protein synthesis,
Fig. 2A showed that TM treatment led to a signiﬁcant (4-fold
after 4 h) and rapid (detectable after 1/2 h) increase in HSP60
mRNA levels (left panel). This induction cannot be abolished
by co-treatment with CX (CX + TM) (Fig. 2A, middle panel),
indicating that induction of HSP60 expression involves a
mechanism that is independent of de novo protein synthesis
in the presence of MycER proteins and is consistent with a di-
rect eﬀect of c-MYC. To ascertain whether c-MYC binds to
the HSP60 promoter, we investigated whether the HSP60 pro-
moter contains c-MYC binding sites. An E-box site (CAC-
GTG) was identiﬁed 1.5 kb upstream from the HSP60
translation start site (ATG) (Fig. 2B). A reporter vector con-Fig. 2. Direct regulation of HSP60 expression by c-MYC. (A) Northern b
hydroxytamoxifen (TM; 500 nM) alone, by TM in the presence of cyclohexam
hybridized to a HSP60 probe and a vimentin probe as a control for RNA l
underneath each panel. (B) Schematic representation of the genomic region en
the reporter constructs used for analysis of transcriptional activation by c-MY
by open and closed triangles) were depicted. The reporter constructs (pHSP6
Transcriptional activation of pHSP60PWLuc, but not pHSP60PMLuc, by
pHSP60PWLuc and expression vectors of c-MYC wild type or its diﬀerent d
deletion mutant was defective in activating pHSP60PWLuc using transien
chromatin prepared from diﬀerent cell lines. Chromatin was incubated with
(c-MYC) antibody. Diﬀerent columns represented experiments using d
EREB.TCMyc(+TC/E2) cells, and EREB.TCMyc(+TC/+E2) cells. The leng
The labeling of control represented the promoter fragments in the HSP60 or
located in the promoter region of HSP60 or HSP90A gene or in the introntaining the HSP60 promoter with the E-box site (pHSP60-
PWLuc; Fig. 2B) was then co-transfected with either the
control pMT2T or the pMT2TMyc expression vector into
293T cells. Fig. 2C showed that c-MYC was able to activate
the expression of pHSP60PWLuc about 2.5-fold. However,
c-MYC was not able to activate the pHSP60PMLuc construct
whose E-box was mutated to CACCTG (Fig. 2B and C), indi-
cating that the E-box in the HSP60 promoter responded to
transcriptional activation by c-MYC. In addition, the c-
MYC mutants lacking the transactivation domain [pMT2-
TMyc(D7–91)] or heterodimerization domain [pMT2T-
Myc(D371–412)] were defective in activating the expression
of pHSP60PWLuc (Fig. 2D). However, the Myc BoxII dele-
tion mutant [pMT2TMyc(D122–140)] was able to activate
the expression of pHSP60PWLuc (Fig. 2D). These results indi-
cated that c-MYC-mediated activation of HSP60 transcription
required both the transactivation and heterodimerization do-
mains, but not the Myc BoxII domain [18]. To determine
whether c-MYC binds to the E-box in vivo, a ChIP assay usinglot analysis of Rat.MycER cells upon activation of MycER by 4-
ide (CX; 10 lg/ml), or with CX alone. The same blots were sequentially
oading. Quantiﬁcation of the ratio of HSP60 vs. vimentin was shown
compassing the 5 0 ﬂanking region of the human HSP60 promoter and
C. E-boxes located in the proximal promoter and intron 1 (represented
0PWLuc and pHSP60PMLuc) were made as described (Section 2). (C)
c-MYC using transient transfection assays. (D) Co-transfection of
eletion mutants showed that the transactivation or heterodimerization
t transfection assays. (E) PCR ampliﬁcation of immunoprecipitated
out antibody (), with an anti-c-Rel (c-Rel) or with an anti-c-MYC
iﬀerent cell lines such as CB33 control cells, CBMyc.Max cells,
ths of diﬀerent PCR fragments were shown in Supplementary Table 3.
HSP90A gene without E-box. Diﬀerent E-boxes represented the E-box
1 region of HSP60 gene. Input is 2% of total input lysate.
Fig. 3. Overexpression of HSP60 induces transformation in a Rat1a cell line in vitro. (A) Western blot analysis showed the increased HSP60 protein
levels in Rat1a clones overexpressing HSP60 (RatHSP60 clones). (B) RatHSP60 clones had increased soft agar colony formation activity compared
to Rat1a control clones (RatCMV). The numbers (5000, 10000, 20000) in the inset indicated the number of cells plated in each plate. Error bars
indicated standard deviations (S.D.).
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Max column). The results showed that c-MYC, but not c-Rel,
bound to the E-box as demonstrated by the c-MYC immuno-
precipitated chromatin ampliﬁable to generate a 220 bp frag-
ment (depicted in Fig. 2B and labeled as E-box (promoter)
in Fig. 2E). Control experiment to amplify another HSP60
promoter fragment (265 bp as depicted in Fig. 2B) which did
not contain an E-box failed to generate an ampliﬁable frag-
ment (labeled as control in Fig. 2E). The 220 bp fragment
was also ampliﬁable from the c-MYC immunoprecipitated
chromatin prepared from EREB.TCMyc(+TC/+E2) cells,
demonstrating the binding of endogenous c-MYC to the E-
box site (Fig. 2E under the EREB.TCMyc(+TC/+E2) column).
In addition, the 220 bp fragment was not ampliﬁable in c-
MYC immunoprecipitated chromatin prepared from CB33
control cells or quiescent EREB.TCMyc(+TC/-E2) cellsFig. 4. The critical role of HSP60 in the transformation activity of RatMyc
RatMyc cells receiving siRNA against endogenous HSP60. Diﬀerent amount
Signiﬁcantly decreased soft agar colony formation activity in RatMyc cells re
20000) in the inset indicated the number of cells plated in each plate. Erro
showed no signiﬁcant decrease in HSP60 protein levels in RatMyc cells rece
decrease in soft agar colony formation activity in RatMyc cells receiving mis
20000) in the inset indicated the number of cells plated in each plate. Error(Fig. 2E under the CB33 or the EREB.TCMyc(+TC/-E2) col-
umn). A positive control experiment using the E-box located in
the HSP90A gene promoter [17] showed a similar intensity of
ampliﬁed PCR fragment by ChIP experiment (labeled as E-box
in Fig. 2E under the HSP90A section). Taken together, these
results indicated that c-MYC directly activates HSP60 tran-
scription by binding to the E-box site located in the HSP60
proximal promoter.
3.3. Induction of transformation by HSP60 in a Rat1a cell line
To test whether HSP60 contributes to transformation activ-
ity caused by c-MYC, Rat1a stable clones overexpressing
HSP60 were generated (Fig. 3A). Soft agar colony formation
assay was performed. The results showed that Rat1a clones
overexpressing HSP60 (RatHSP60) had increased soft colony
formation activity compared to the control Rat1a clones (Rat-cells. (A) Western blot analysis showed the decreased HSP60 levels in
s of pSUPER-rhsp60i plasmids were transfected into RatMyc cells. (B)
ceiving siRNA against endogenous HSP60. The numbers (5000, 10000,
r bars indicated standard deviations (S.D.). (C) Western blot analysis
iving mismatched or scrambled siRNA as controls. (D) No signiﬁcant
matched or scrambled siRNA as controls. The numbers (5000, 10000,
bars indicated standard deviations (S.D.).
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of transformation mediated by c-MYC.
3.4. The critical role of HSP60 in c-MYC mediated
transformation
To determine whether the role of HSP60 is critical in the
induction of transformation caused by c-MYC, RatMyc cells
were transiently transfected with pSUPER-rhsp60i plasmid
to repress endogenous HSP60 (Fig. 4A). Soft agar colony for-
mation assays were performed comparing the RatMyc cells
receiving siRNA against HSP60 vs. the control RatMyc clone.
The results showed that there was a signiﬁcant decrease in
transformation activity in RatMyc cells receiving siRNA
against HSP60 (Fig. 4B), demonstrating the critical role of
HSP60 in the induction of transformation by c-MYC. Control
experiments using pSUPER plasmids expressing mismatched
siRNA (pSUPER-rhsp60iM) or scrambled siRNA (pSU-
PER-scrambled) did not cause a decrease in HSP60 protein
levels (Fig. 4C) or transformation activity of RatMyc cells
(Fig. 4D), supporting the speciﬁcity of pSUPER-rhsp60i plas-
mid used to repress endogenous HSP60 in RatMyc cells. These
results demonstrated the critical role of HSP60 in c-MYC med-
iated transformation.4. Discussion
Collectively, our results demonstrated that HSP60 expres-
sion is regulated by c-MYC and overexpression of HSP60 in-
duces transformation. HSP60 was shown to be a putative c-
MYC target gene [19–23]. Our detailed characterization using
diﬀerent cell lines and identiﬁcation of an E-box site in the
proximal promoter of the HSP60 genes further demonstrated
that HSP60 is a direct c-MYC target gene. Although the
Myc BoxII deletion was shown to impair most of the transac-
tivation activity mediated by wild type Myc, it was shown that
a small proportion of c-Myc target genes could still be acti-
vated by Myc BoxII deletion mutant [18]. From our results,
it was possible that HSP60 may belong to this kind of target
genes not requiring the transactivation function of Myc BoxII
domain (Fig. 2D). Soft agar colony formation assays sup-
ported its possible role in c-MYC mediated transformation.
siRNA mediated repression of HSP60 in RatMyc cells signiﬁ-
cantly decreased the transformation activity.HSP60 activation
may be a crucial component of the program by which consti-
tutive c-MYC expression induces transformation.
Increased HSP60 expression is observed in diﬀerent types of
human cancers (ovarian cancer, pancreatic cancer, large bowel
carcinoma, etc.) [11–13]. However, the role of increased HSP60
expression in tumorigenesis is relatively unknown. Our demon-
stration that overexpression of HSP60 induces soft agar colony
formation in a Rat1a cell line is consistent with its role to con-
tribute to transformation and tumorigenesis in diﬀerent types
of human cancers. Recently, HSP60 was shown to stabilize
mitochondrial survivin and inhibit apoptosis in tumor cells,
which also supports the tumorigenic role of HSP60 [24].
HSP60 was mostly shown to be involved in innate immunity
and cardiac diseases [9,10] in contrast to our demonstration
of its role in transformation. Taken together, our results
demonstrated the direct regulation of HSP60 expression by
c-MYC and the critical role of HSP60 in c-MYC mediated
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